Psyence Biomedical Ltd.
13F holders, Q4 2025 (December 31)4holders −2
1new positions
3sold out
$0.76avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding Psyence Biomedical Ltd. in their 13F filings, down 2 from Q3 2025. 1 opened new positions and 3 sold out. The largest holders were Virtu Financial LLC ($28K), Bank of America Corp. ($3K) and UBS Group AG ($758).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F308
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $758 |
| Exits | 3 | $718K |
All 13F filers, Q3 2025 → Q4 2025: 27,730 shares bought and 161,128 shares sold, net −133,398 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Virtu Financial LLC | 0.00% | Add +258.8% | 37,042 | $28K |
| Bank of America Corp. | 0.00% | Add +0.2% | 3,346 | $3K |
| UBS Group AG | 0.00% | New | 1,007 | $758 |
| Stonehage Fleming Financial Services Holdings Ltd | 0.00% | No change | 561 | $422 |
"% of holder's portfolio" is PSYENCE BIOMEDICAL LTD's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.